Angrist B, Peselow E, Rubinstein M, Corwin J, Rotrosen J
Psychopharmacology (Berl). 1982;78(2):128-30. doi: 10.1007/BF00432248.
In stable schizophrenic outpatients with predominantly "defect state" symptomatology amphetamine caused a reduction in negative symptoms that was statistically significant but not complete (i.e. these symptoms remained clinically discernible). The possibility that dopaminergic hypofunction contributes some elements to the schizophrenic defect state is presented, along with some limited data compatible with this concept. These findings are compared to prior studies in recently hospitalized schizophrenic subjects, and discussed with respect to recent theoretical concepts regarding the role of dopamine in schizophrenic psychopathology.
在以“缺陷状态”症状为主的稳定型精神分裂症门诊患者中,苯丙胺可使阴性症状有所减轻,这一减轻具有统计学意义,但并不完全(即这些症状在临床上仍可辨别)。文中提出多巴胺能功能减退对精神分裂症缺陷状态有一定影响的可能性,并列举了一些与此概念相符的有限数据。将这些发现与之前对近期住院的精神分裂症患者的研究进行比较,并结合多巴胺在精神分裂症精神病理学中作用的最新理论概念进行讨论。